Company intelligence / Profile preview

AtaCor Medical

San Clemente, California, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Preclinical

Overview

AtaCor Medical has developed a proprietary extravascular system for delivering both temporary and permanent bradycardia pacing therapy without the need for vascular access or device placement within/on the heart. The technology aims to reduce complications associated with traditional transvenous leads and allows rapid deployment without imaging. The company has initiated clinical studies such as ASCEND EV.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically cardiac pacing and defibrillation systems)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on AtaCor Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AtaCor Medical.

Explore the full profile